{"date":"2025-03-08","count":1,"source":"公開資訊觀測站（MOPS）","attribution":"引用請註明：Drugnews 事實帳本（https://drugnews.com.tw/filings/）與公開資訊觀測站原始公告","records":[{"id":"tw-7754-2025-03-08-0934-h9kaor","company_id":"7754","company":"安基生技","market":"興櫃","industry":"生技醫療","date":"2025-03-08","time":"09:34:22","subject":"本公司回應美國Avenue Therapeutics, Inc.所發布之訊息及相關因應措施","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：安基生技（7754），2025-03-08 09:34，「本公司回應美國Avenue Therapeutics, Inc.所發布之訊息及相關因應措施」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"}]}